Obesidad: lo viejo, lo nuevo y cómo lo gestionamos: un enfoque integrado en la práctica farmacéutica
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
1. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402-24.
2. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.
3. González Jiménez E. Obesity: Etiologic and pathophysiological analysis. Endocrinología y Nutrición (English Edition). 2013;60(1).
4. Clarke W, Dasgupta A. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. 2016.
5. Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Vol. 66, Canadian Family Physician. 2020.
6. Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes and Metabolism Journal. 2020; 44.
7. Kosmalski M, Deska K, Bąk B, Różycka-Kosmalska M, Pietras T. Pharmacological Support for the Treatment of Obesity—Present and Future. Vol. 11, Healthcare (Switzerland). 2023.
2. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.
3. González Jiménez E. Obesity: Etiologic and pathophysiological analysis. Endocrinología y Nutrición (English Edition). 2013;60(1).
4. Clarke W, Dasgupta A. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. 2016.
5. Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Vol. 66, Canadian Family Physician. 2020.
6. Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes and Metabolism Journal. 2020; 44.
7. Kosmalski M, Deska K, Bąk B, Różycka-Kosmalska M, Pietras T. Pharmacological Support for the Treatment of Obesity—Present and Future. Vol. 11, Healthcare (Switzerland). 2023.
Jesus, Ângelo. (2023). Obesidad: lo viejo, lo nuevo y cómo lo gestionamos: un enfoque integrado en la práctica farmacéutica. FarmaJournal, 8(2), 45–46. https://doi.org/10.14201/fj2023824546
Artículos similares
- Mihaela Metodieva, José Enrique Fuentes, Atención farmacéutica en obesidad. Utilidad de las plantas medicinales en su tratamiento , FarmaJournal: Vol. 1 Núm. 2 (2016)
También puede {advancedSearchLink} para este artículo.
Descargas
Los datos de descargas todavía no están disponibles.
+
−